UBS Group’s KraneShares Emerging Markets Healthcare Index ETF KMED Stock Holding History

UBS Group’s Portfolio KMED Stock Details KMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-356	Closed	-$7.33K	–	10224
2023 Q2	$7.33K	Sell	356 -391	-52%	-$8.31K	﹤0.01%	7302
2023 Q1	$15.7K	Sell	747 -214	-22%	-$4.72K	﹤0.01%	7278
2022 Q4	$21.1K	Sell	961 -122	-11%	-$2.57K	﹤0.01%	7590
2022 Q3	$21K	Hold	1,083	–	–	﹤0.01%	7361
2022 Q2	$25K	Buy	1,083 +396	+58%	+$8.77K	﹤0.01%	6626
2022 Q1	$17K	Buy	687 +10	+1%	+$250	﹤0.01%	7692
2021 Q4	$19K	Sell	677 -249	-27%	-$7.2K	﹤0.01%	7930
2021 Q3	$29K	Buy	926 +71	+8%	+$2.34K	﹤0.01%	6797
2021 Q2	$31K	Sell	855 -586	-41%	-$20.9K	﹤0.01%	6903
2021 Q1	$49K	Buy	+1,441	New	+$51.4K	﹤0.01%	6586
2020 Q4	–	Sell	-70	Closed	-$2K	–	8912
2020 Q3	$2K	Buy	+70	New	+$2.17K	﹤0.01%	7713
2020 Q2	–	Sell	-280	Closed	-$6K	–	8489
2020 Q1	$6K	Buy	+280	New	+$6.11K	﹤0.01%	7252

Other funds holding KMED

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group's KMED Position: Q3 2023 in Review

UBS Group sold out of KraneShares Emerging Markets Healthcare Index ETF (KMED) in Q3 2023, closing a stake of 356 shares — an estimated $7.33K sold.

UBS Group first reported a position in KMED in Q1 2020 and held it in 12 quarters. The position peaked at $49K in Q1 2021. 1 fund tracked by Wall St. Rank holds KMED as of Q3 2023.

UBS Group reported no remaining KraneShares Emerging Markets Healthcare Index ETF position as of Q3 2023 after selling out during the quarter.
UBS Group sold 356 KraneShares Emerging Markets Healthcare Index ETF shares in Q3 2023, an estimated $7.33K.
UBS Group first reported a position in KraneShares Emerging Markets Healthcare Index ETF in Q1 2020 and held it in 12 quarters.
UBS Group's KraneShares Emerging Markets Healthcare Index ETF position peaked at $49K in Q1 2021.
1 fund tracked by Wall St. Rank held KraneShares Emerging Markets Healthcare Index ETF as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.